ING Groep »

Mirati Therapeutics shares owned by ING Groep

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by ING Groep from 13F filings

Historical chart of ING Groep investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by ING Groep consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by ING Groep

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 40k 58.75

More positions owned by ING Groep

Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Qualcomm (QCOM)
Cedar Fair Depositry Unit (FUN)
Merck & Co (MRK)
Intel Corporation (INTC)
Costco Wholesale Corporation (COST)
Texas Instruments Incorporated (TXN)
Adobe Systems Incorporated (ADBE)

View all positions for ING Groep

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics